Results 51 to 60 of about 69,031,262 (351)

COVID-19 Treatment Guidelines

open access: yes, 2022
The COVID-19 Treatment Guidelines provide clinicians with evidence-based recommendations on the management of COVID ...
Hinkson, Carl R   +1 more
core   +1 more source

COVID‐19 associated EBV reactivation and effects of ganciclovir treatment

open access: yesImmunity, Inflammation and Disease, 2022
Background Systemic reactivation of Epstein–Barr virus (EBV) may occur in novel coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2).
Mei Meng   +9 more
doaj   +1 more source

Myanmar: The impact of COVID-19 and food system responses

open access: yes, 2021
In Myanmar, the COVID-19 pandemic and political upheaval have both had significant economic and social repercussions. CGIAR has been working with partners in the country to assess the economic impacts of the pandemic and their consequences for agrifood ...
COVID-19 Hub, COVID Hub
core   +1 more source

Multidrug treatment for COVID-19

open access: yesDrug Discoveries & Therapeutics, 2021
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which began in Wuhan, China in December 2019, has rapidly spread all over the world. The World Health Organization characterized the disease caused by SARS-CoV-2 (COVID-19) as a pandemic in March 2020.
Ohe, Masashi   +2 more
openaire   +4 more sources

Can Zn Be a Critical Element in COVID-19 Treatment?

open access: yesBiological Trace Element Research, 2020
The current COVID-19 pandemic caused by SARS-CoV-2 has prompted investigators worldwide to search for an effective anti-viral treatment. A number of anti-viral drugs such as ribavirin, remdesivir, lopinavir/ritonavir, antibiotics such as azithromycin and
Mohammad Tariqur Rahman, S. Idid
semanticscholar   +1 more source

Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study

open access: yesArchives of Virology, 2021
No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19.
H. Dabbous   +9 more
semanticscholar   +1 more source

Nigeria: The impact of COVID-19 and food system responses

open access: yes, 2021
As Nigeria continues to face the effects of the COVID-19 pandemic, CGIAR and partners have expanded access to quality seeds and improved crop varieties, strengthened capacity of women and youth, and informed national responses and policies with evidence ...
COVID-19 Hub, COVID Hub
core   +1 more source

Pharmacological Treatment for the Management of COVID 19: A Narrative Review

open access: yesJournal of Nepal Medical Association, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is alarming worldwide incurring tremendous loss of life and possession. Individuals are facing a terrible pandemic condition in the absence of appropriate medicines and vaccines to ...
Neelam Dhakal   +2 more
doaj   +1 more source

Etoposide as Salvage Therapy for Cytokine Storm due to COVID-19

open access: yes, 2020
Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality because of a lack of effective therapies. Therapeutic strategies under investigation target the overactive cytokine response with anti-cytokine or immunomodulators ...
Bromberg, Michael   +10 more
core   +1 more source

Ethiopia: The impact of COVID-19 and food system responses

open access: yes, 2021
In Ethiopia, the COVID-19 pandemic has affected livelihoods and caused declines in the gross domestic product (GDP) of the agrifood system (AFS) as well as in total GDP.
COVID-19 Hub, COVID Hub
core   +1 more source

Home - About - Disclaimer - Privacy